It has been suggested that the rate of CD4 cell decline accelerates in parallel with decreasing numbers of cells; however, the statistical literature suggests the opposite. CD4 cells were counted about every 6 months in a cohort of 1264 human immunodeficiency virus -infected subjects (the Italian Seroconversion Study cohort). Kaplan-Meier analysis was used to estimate the time for CD4 cells to decline by 100 cells/mm 3 , conditional on reaching predefined levels. In addition, CD4 cell counts were modeled as a function of time since seroconversion in individuals with §5 counts. Kaplan-Meier survival times for a 100 cell/mm 3 decrease in CD4 cells increased as lower counts were reached (log rank test, P õ .001). The shape of the overall fitted curve of the CD4 cell counts does not suggest an increasing rate of decline. Data from the Italian Seroconversion Study cohort do not show a general tendency for accelerating CD4 cell decline in association with lower counts.
Given the likely central role of CD4 lymphocyte decline in Methods AIDS pathogenesis, it is important to have a clear description of Data source. We derived data from 16 outpatient facilities the typical pattern with which CD4 lymphocytopenia develops. 
ing the course of HIV infection show CD4 cells declining at
More detailed information on data collection is reported elsewhere an accelerating rate at some point. There has also been the [14] . For this analysis, we considered only subjects with at at least suggestion of a ''precipitous decline'' in CD4 cells before the 2 CD4 cell measurements.
We considered the absolute CD4 cell count, rather than the diagnosis of AIDS [1 -5] . In contrast, the statistical literature 3 and subsequently fell, it was Higher order terms (e.g., quadratic or cubic) can be added either as fixed or random parameters. Terms were included in assumed for the Kaplan-Meier analysis of time for decline from 500 to 400 cells/mm 3 that this was the first time the subject's CD4 the model if they resulted in a significant improvement in fit to the model. Improvement in fit is assessed by log-likelihood ratio cell count had been õ500 cells/mm 3 . If the time from seroconversion to the first measured count was long, this assumption is less tests by comparing the change in 21 log-likelihood to a x 2 distribution with degrees of freedom equal to the number of extra likely to hold.
To account for possible laboratory error and random daily variaparameters fitted. These analyses were done using the statistical package ML3 [23] . tion that could have affected some measurements, the analysis was done with the expectation that the subject reached a specific cutoff
There is evidence that it is appropriate to model changes in the CD4 cell count on a square root scale [11, 24] . This transformation as soon as he experienced the first of two consecutive counts below the cutoff, rather than only one count below the cutoff.
ensures the fitted values of CD4 cells are not negative. Further, while variation in CD4 cell count at the within-individual level To assess whether persons excluded from the analysis had a different course of HIV infection than those included, we compared can be explicitly built into the multilevel model if desired, previous studies have shown that the square root transformation essentially progression to AIDS in the 2 groups. The AIDS-free survival time was measured from the estimated date of seroconversion to the stabilizes the variation in the CD4 cell count over time [11] . However, the modeling was repeated using untransformed CD4 cell date of AIDS diagnosis, the date of non-AIDS death, or to July 1994. AIDS diagnoses were cross-checked with the Italian Naand log-transformed counts for comparison. Because the conclusions were essentially similar, we present results only after taking tional AIDS Registry as described elsewhere [20] .
As a further means of assessing the pattern of CD4 cell decline the square root transformation. The existence of a distinct group of long-term nonprogressors over time, a multilevel approach [21] was used to model the relationship between the CD4 cell count and the time since seroconverwho maintain high CD4 cell counts for substantial periods has been suggested [25] . These individuals, if they exist [26] , may sion in subjects with §5 CD4 cell measurements. This method was previously used to model the pattern of CD4 cell decline [11, have an effect on the estimates of the overall pattern of decline.
To avoid possible biases due to such an effect, we repeated the 22] and provides efficient estimates of the pattern of the decline while taking into account the fact that measurements within a analysis, fitting the final model to exclude all subjects whose CD4 cell counts never fell below 500 cells/mm 3 and who were likely person are correlated. A two-level model is fitted. Level 1 is the variation in CD4 cell counts that can be explained within an indito be long-term nonprogressors in our cohort. To assess whether a further different pattern of decline was evident in those who vidual at any point in time. This may include variation due to laboratory methods, time of day, or other natural biologic variation.
progressed, the analysis was also repeated including only subjects whose CD4 cell counts fell below 100 cells/mm 3 . Level 2 is the variation in CD4 cell counts that describes how CD4 cell decline patterns vary among individuals. The method used is similar to fitting separate regression models for each person,
Results
although unlike simple regression, the estimated parameters are constrained to come from some parametric distribution, usually a Among 1264 subjects enrolled up to November 1993, 1021 normal distribution. Parameters may be ''fixed'' in that each sub-(81%) had at least 2 CD4 cell counts. For 75% of the subjects, ject has the same value as each other, that is, a common intercept the seroconversion interval (time between the last HIV-negaor slope, or ''random'' in that each subject's parameter can vary tive and the first HIV-positive test) was õ1 year and for 95% with a given distribution (i.e., different slopes and intercepts).
it was õ2 years. Among the subjects with §5 CD4 cell counts, The simple multilevel model in the untransformed scale of CD4 cell counts can be described as:
this interval was even narrower (95% seroconverted within 21 / e ij , where CD4 ij is the CD4 cell count for patient i at time t j , a months). Progression to AIDS did not differ between this group and b are fixed quantities, the average CD4 cell count at seroconof patients and those with õ2 counts; an AIDS cumulative version (the intercept) and the average rate of decline (the slope), incidence of 20% was observed Ç6 years after the estimated u i is the extent to which the ith individual departs from the average seroconversion date in both groups.
intercept, v i is the extent to which the ith individual departs from 3.6 months (when the starting count was §800 cells/mm 3 ) to precipitous decline that occurs immediately after seroconversion [27, 28] . Unfortunately, we did not have sufficient data to 16.7 months (when the starting count was §200 cells/mm 3 ). The same tendency was observed when the analysis was done verify this issue, since for Ç50% of those with §5 CD4 cell counts, the first measurement was assessed §6 months after by censoring patients at 1 January 1989, by time of first treatment, or by excluding subjects whose first CD4 cell count was the estimated date of seroconversion. Also, there was wide variation among cohort subjects. Square root transformed CD4 ú6 months after the estimated seroconversion date (data not shown). When we performed the analysis considering 2 conseccell counts at seroconversion were estimated to range from 15.22 to 37.38 in 95% of patients (corresponding to absolute utive CD4 cell counts below the cutoff point necessary to define a patient as having declined below it (instead of a single count), counts of 232 and 1397 cells/mm 3 ), and rates of square root transformation varied from a drop of 7.2 per year to an increase the results were similar. We also repeated the analysis allowing each patient to contribute to only one Kaplan-Meier analysisof 3.8 per year. However, as shown in figure 1 , there was no evidence of a general tendency for the rate of CD4 cell decline the one involving the highest CD4 cell count. Again, median times to decline by 100 cells/mm 3 were longer at lower counts. to speed up over time; also the estimated rate of decline from fitting the model (the second derivative of CD4 cell count with A log-rank test that compared the seven Kaplan-Meier curves was highly significant (x 2 Å 76.7, P õ .001). respect to time) is a nonnegative function of time (5.98 0 0.06 time / 0.0001 time 2 ) , suggesting that the decline becomes Figure 1 shows the overall fitted curve for the CD4 cell count transformed back onto the original scale. The inclusion slower. CD4 cell counts fell below 500 cells/mm 3 in 549 subjects of a linear rate of decline for square root transformation of CD4 cell counts over time, which was allowed to vary between (88%) with §5 CD4 cell counts and below 100 cells/mm 3 in 135 (22%). When the multilevel model was refitted using only individuals, was highly significant (P õ .001). The addition of a random quadratic coefficient of time also explained a signifithese 2 subgroups of subjects, the results were essentially unchanged. The fixed quadratic coefficient remained nonsignificant amount of variation between patients (P õ .001), although the overall mean coefficient was not significantly different from cant in both analyses (P Å .48 and P Å .21, respectively), indicating that the overall pattern of CD4 cell decline was not zero (P Å .89), suggesting that while square root transformation of CD4 cell counts declined in a quadratic manner in some affected even by the inclusion of possible long-term nonprogressors or of subjects with disease progression. persons, there was no consistent pattern to the sign of the coefficient (i.e., the direction of curvature) among subjects. For Ç49% of the subjects included in this analysis, the estimated coefficient associated with the quadratic term was positive (i.e., Discussion the estimated trajectory was one of slower decline for decreasing level of square root transformation of CD4 cell count).
These results clearly indicate that although there is wide variability in the pattern of CD4 lymphocyte decline among The mean square root transformation of CD4 cell counts at seroconversion was estimated to be 26.3, with the transformed individuals, the rate of decline does not tend, on average, to be faster at lower counts than at higher counts. Our findings count dropping a mean of 1.68 per year and with a small positive quadratic coefficient of 0.003. Thus, while the CD4 are consistent with reports in the statistical literature of analyses of longitudinal CD4 cell data [6 -13] and have fundamental cell count is estimated to be a mean of 692 cells/mm 3 at seroconversion, by 10 years after seroconversion it will have fallen implications for understanding the cause of CD4 cell decline during HIV infection. Models of AIDS pathogenesis must recto 89 cells/mm 3 on average. The estimated level at seroconversion is slightly lower than the CD4 cell count generally oboncile the decreasing rate of CD4 cell decline with the concomitant increase in virus burden [13, 29 -33] . served in HIV-negative persons and it is likely due to the / 9d21$$ap15 02-04-97 18:06:46 jinfa UC: J Infect We realized that in percentage terms, a change from say 600 contributed to several such analyses, those with rapidly declining cells might be overrepresented, resulting in an underestito 500 cells/mm 3 is less of a change than from 200 to 100 cells/mm 3 , which represents a halving in absolute count. Nonemate of time for CD4 cells to drop by 100 cells/mm 3 at lower numbers. However, if anything, this is likely to bias the results theless, even in these terms, the average time for the decline of 200 to 100 CD4 cells/mm 3 (16.7 months, see table 1) was towards underestimating the time to decline by 100 cells/mm 3 at low CD4 cell counts. For subjects whose CD4 cells declined only about half that needed for a decline from 600 to 300 cells/mm 3 (37.2 months, data not shown), a small difference rapidly, the first count might be low, so they would only be included in the lower count analyses. Again, this should result compared with the 10-to 100-fold difference in virus burden between those with 600 and those with 200 CD4 cells/mm 3 in bias towards underestimating the time to decline by 100 cells/mm 3 at low cell numbers. [29 -33] . We primarily concentrated on the absolute decline in CD4 cells (i.e., on a linear scale) rather than percentage terms Another issue is that we assumed that a subject's CD4 cell levels had not previously fallen below the value at study entry. (i.e., on a logarithmic scale), because CD4 cell changes are usually considered linear [15 -19] . We believe models of HIV This is less likely to be true for subjects with higher starting levels, thus resulting in greater underestimation of the median pathogenesis must be able to explain the dissociation between virus burden and decline in CD4 cells if they are to be considtime for a 100 cell/mm 3 decline at higher initial CD4 cell levels. In an attempt to address this potential bias, we reanalyzed the ered realistic.
Before drawing firm conclusions, possible biases and limitadata after excluding patients whose first CD4 cell count was obtained ú6 months after the estimated date of seroconversion. tions of our study should be discussed. First, subjects were excluded from our analysis if they had õ2 CD4 cell counts.
The results were similar. Also, the increasing trend in time for a 100 cell/mm 3 decline was not affected by random errors in If there was a tendency for CD4 cells in these subjects to decline more or less rapidly than the subjects included, a bias CD4 cell measurements, since the results did not change when a subject was deemed to have reached the cutoff after the first may exist. However, we found that progression to AIDS was similar in the 2 groups. Furthermore, the proportion of persons of 2 consecutive counts below the cutoff. A group of subjects in the cohort with low CD4 cells was given antiretroviral drugs. excluded was similar at each starting cell count ( §800 cells/ mm 3 , 700 to 800, etc.).
This would produce a bias towards slower decline in CD4 cell counts at low levels, since treatment is likely to prolong surSecond, a bias could arise due to the inclusion of subjects in more than one Kaplan- (only 9% of the subjects were treated before this date) and Tirelli, CRO, Aviano.
by censoring individuals at the point they received their first treatment. Again, these analyses showed a similar trend in CD4 cell decline (data not shown).
